Novartis becomes a tenant on its own site
The pharmaceutical company sells its premises in Stein im Fricktal. The buyer is Getec, which already leases areas in Schweizerhalle.
At the Stein site in nearby Friktal, Novartis wants to focus on its core business, making medicines. The company has therefore decided to hand over the further development of Life Science Park Rheintal at Stein AG to Getec, “a specialist in professional industrial parks and energy solutions,” as stated in a press release. The statement confirmed that Novartis will continue to be the largest tenant in the Rienthal Life Sciences Park. However, assets and services related to real estate and infrastructure will be transferred to Getec.
It was agreed not to disclose the terms of the sale. Getec plans to continue the long-term development of Life Science Park Rheintal and invest in the site in order to attract new tenants. About a third of the area in Stein is currently unused. Getec is not an unknown player in the region. The company already operates the Getec Swiss Park in Schweizerhalle, where Novartis is active, among others. Favorite
“Tv expert. Hardcore creator. Extreme music fan. Lifelong twitter geek. Certified travel enthusiast. Baconaholic. Pop culture nerd. Reader. Freelance student.”